SCHEMBL6422639

SCHEMBL6422639

Cc1c[nH]nc1-c1ncc(F)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.56
CYP2C19 P33261 6/20 0.52
CYP2D6 P10635 5/20 0.52
CYP3A4 P08684 3/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2B6 P20813 1/20 0.52
KCNH2 Q12809 1/20 0.52
CKS1B P61024 1/20 0.38
SKP1 P63208 1/20 0.38
SKP2 Q13309 1/20 0.38
BTK Q06187 1/20 0.38
SMO Q99835 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALOX15 P16050 1/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.34
KIT P10721 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426124 0.89 CYP2C9 (0.73) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL13390508 0.86 CYP2C9 (0.53) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL12649356 0.85 CYP2C9 (0.61) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763439 0.85 CYP2C9 (0.55) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763320 0.85 CYP2C9 (0.55) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL2629182 0.83 CYP2C9 (0.54) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL12751256 0.83 CYP2C9 (0.53) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL2629176 0.83 CYP2C9 (0.55) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL1763490 0.83 CYP2C9 (0.54) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2
SCHEMBL6433552 0.83 CYP2C9 (0.81) CYP2C9CYP2C19CYP2D6CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549313-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES Bristol-Myers Squibb Company (US) 2005-07-06 EP disclosed
WO-2004014380-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-02-19 WO disclosed